ArticleClinical and translational medicine2022

PI3K-α/mTOR/BRD4 inhibitor alone or in combination with other anti-virals blocks replication of SARS-CoV-2 and its variants of concern including Delta and Omicron.

Arpan Acharya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.